Kettle Hill Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Kettle Hill Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $326,028 - $594,646	41,906 New	41,906 $336,000
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $170,824 - $338,186	38,474 New	38,474 $175,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $539,559 - $960,070	96,007 New	96,007 $613,000
Q2 2022 Dec 08, 2022	BUY	$6.38 - $18.33 $522,892 - $1.5 Million	81,958 New	81,958 $905,000

318

242M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $963M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Kettle Hill Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kettle Hill Capital Management, LLC with notifications on news.